Neurochemical Mechanisms in Disease P24 pdf
Neurochemical Mechanisms in Disease P24 pdf
... cAMP-responsive
element-binding protein; CYFIP, cytoplasmic FMR1 interacting protein; FMRP, fragile X syn-
drome protein; LIM, Lin-11, Isl-1 and Mec-3 kinase; MEGAP, Mental disorder-associated GAP
protein; MLC, myosin ... inhibiting a
key effector of RhoA, termed Rho-kinase (Govek et al., 2004). As discussed above,
Rho-kinase can in uence the actin cytoskeleton by acting on LIM kinase (LIMK)...
Neurochemical Mechanisms in Disease P3 pdf
... value of treating it with extracts of cinchona bark, whose active prin-
ciple we now recognize to be quinine. This eminently practical approach—clinical
signs and symptoms indicating the need ... useful
that it came to dominate medicine, not only in Britain but also in other countries.
Because Sydenham’s concept included response to a particular treatment (often a
medicine containing one...
Neurochemical Mechanisms in Disease P14 pdf
... by hyperargininemia in the cerebellum
and hippocampus of rats (Delwing et al., 2006). Vitamin C and E administration,
alone or in combination, increases striatal catalase activity in rats subjected ... trans-
fer protein (αTP) in the brain. Dysfunction of αTP results in deficiency of vitamin
E in humans and mice, and increased oxidative stress i n mouse brain. Ataxia
with isolated...
Neurochemical Mechanisms in Disease P17 pdf
... is meningoencephalitis, there is brain edema in the adjacent
brain. Occasionally the in ammation around the blood vessels penetrating the brain
causes a stroke further aggravating the injury ... meningitis is by definition
limited to the meninges and does not lead to brain edema. However, in some individ-
uals there is penetration of the organisms into the brain along the Virchow–Robin
sp...
Neurochemical Mechanisms in Disease P22 pdf
... function,
playing a part in many brain pathologies including Alzheimer’s, Huntington’s,
and Parkinson’s diseases and olivopontocerebellar atrophy, which are commonly
Glutamate and Glutamine in Brain Disorders ... increased interest in employing NMRS in studying these pathologies
and representative studies are discussed below.
Glutamate metabolism and glutamate–glutamine cycling might...
Neurochemical Mechanisms in Disease P28 pdf
... and feedback connections. Amacrine cells, including dopamine amacrine
cells, are located in the inner layer close to ganglion cells (Fig. 4). The inner retina
(IRL) includes the nerve fiber layer, ... Bodis-Wollner and H. Moreno
6.4 Dopamine in Visual Processing in the Retina
The retina is multilayered, with distinct neural elements in each layer. Receptors in
the outer layers conver...
Neurochemical Mechanisms in Disease P62 pdf
... Alzheimer’s
disease and diabetes. Behav Brain Res 75:1–11
Messier C, Teutenberg K (2005) The role of insulin, insulin growth factor, and insulin-degrading
enzyme in brain aging and Alzheimer’s disease. ... suggest that Pin1 plays a role in APP
processing, and therefore, in Aβ levels in brain (Pastorino et al., 2006). Thus, Pin1
is involved in two of the major pathological hallmar...
Neurochemical Mechanisms in Disease P66 pdf
... been divided into two large domains such as
projection domains (containing the amino terminal two-thirds of the molecule) and
the microtubule binding domain (containing the carboxy terminal one-third ... subdivided
into the basic, true tubulin-binding region and the acidic carboxy terminal region.
Several distinct roles have been proposed for the projection domain including that
of determinin...
Neurochemical Mechanisms in Disease P70 pdf
... brain calcium binding
proteins, calmodulin and S100b protein. Biochem Biophys Res Commun 114:1138–1146
Beaulieu C, Dyck R, Cynader M (1992) Enrichment of glutamate in zinc-containing terminals ... cells (Kleineke and
Brand, 1997; Rivlin et al., 1999) where it likely plays a role in insulin transport. In
mice ZnT-8 has limited expression in brain.
4 Zinc, Zinc Transport, Alzheimer’s D...
Neurochemical Mechanisms in Disease P76 pdf
... Bhatia KP, Quinn N, Brooks D, Lees AJ, Davis MB, Piccini P,
Singleton AB, Wood NW (2005) Mutations in the gene LRRK2 encoding dardarin (PARK8)
cause familial Parkinson’s disease: clinical, pathological, ... imaging and
genetic data. Brain 128:2786–2796
Khan NL, Valente EM, Bentivoglio AR, Wood NW, Albanese A, Brooks DJ, Piccini P (2002)
Clinical and subclinical dopaminergic dysfunction in...
Từ khóa: